| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.008 |